Skip to main content
Clinical Trials/NCT05753683
NCT05753683
Recruiting
N/A

GODDESS (Gathering Online for Dialogue and Discussion to Enhance Social Support): Engaging Young African American Women in a Virtual Group App to Address Alcohol Misuse, Sexual Risk, and Pre-exposure Prophylaxis (PrEP) in North Carolina (NC)

RTI International1 site in 1 country500 target enrollmentApril 7, 2025

Overview

Phase
N/A
Intervention
Not specified
Conditions
Alcohol Misuse
Sponsor
RTI International
Enrollment
500
Locations
1
Primary Endpoint
Alcohol (Biological)
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

The goal of this trial is to test a modified mobile health intervention (with a group component) relative to a mobile health intervention in a two-arm randomized trial with 500 young African American women who are human immunodeficiency virus (HIV)-negative and who misuse alcohol.

The expected outcomes are to: (1) determine the efficacy of the virtual group component in reducing alcohol use and sexual risk and increasing pre-exposure prophylaxis (PrEP) utilization; and (2) understand selected outcomes for implementation.

Participants will be randomized to receive either the mHealth app or the mHealth app plus the group component, and followed up at 3- and 6-months post-enrollment.

Detailed Description

A total of 500 participants who are human immunodeficiency virus (HIV)-negative who engage in heavy alcohol use will be enrolled and referred to their local health departments for pre-exposure prophylaxis (PrEP). Primary biobehavioral outcomes assessed will include reduced alcohol use (self-reported and biological, including phosphatidylethanol \[PEth\]), increased PrEP uptake (self-reported and biological), and reduced sexual risk (self-reported condomless sex and impaired sex and biological testing for HIV) at 3- and 6-month follow-up.

Registry
clinicaltrials.gov
Start Date
April 7, 2025
End Date
April 2027
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Felicia A. Browne, ScD, MPH

Senior Research Social Epidemiologist

RTI International

Eligibility Criteria

Inclusion Criteria

  • identify as Black/African American
  • identify as female
  • be between 18 and 30 years old
  • recent substance use
  • HIV negative and not currently on PrEP
  • have an Android or iOS-based smartphone

Exclusion Criteria

  • test positive for HIV
  • participated in the previous study activities of the current study or previous related studies

Outcomes

Primary Outcomes

Alcohol (Biological)

Time Frame: 6-month

Phosphatidylethanol (PEth) in dried blood spots (DBS) with concentration equal to or greater than 8 ng/mL is an indication of alcohol exposure in the last 2-4 weeks (approximately). Higher concentrations of PEth indicates higher recent alcohol consumption.

Alcohol (Self-Reported)

Time Frame: 6-month

World Health Organization's Alcohol, Smoking \& Substance Use Involvement Scale (ASSIST) assesses risk for alcohol consumption problems via 8 items. Scores range from 0 to 39, and this score indicates level of risk for alcohol consumption problems. Scores from 0 to 10 indicate lower risk for alcohol problems, scores from 11 to 26 indicate moderate risk, and scores from 27 to 39 indicate high risk.

Sexual Risk: HIV (Biological)

Time Frame: 6-month

Number of participants living with HIV as assessed by OraQuick® ADVANCE Rapid HIV-1/2 Antibody Test with oral fluid, with an approximate 99.3% sensitivity \& 99.8% specificity, which detects antibodies to HIV-1 and HIV-2.

Sexual Risk (Self-reported)

Time Frame: 6-month

Revised Risk Behavior Assessment (RRBA): Condomless vaginal or anal sex, impaired sex (AOD use prior to or during sex), casual partners, sex trading, \& concurrent partners (≥2 partners), other contraceptive use, \& perception of risk, HIV, recent STIs

PrEP Utilization (Biological)

Time Frame: 6-month

Dried blood spot (DBS) samples will be analyzed by quantification of drug concentrations by liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology using assays validated at the study laboratory.

PrEP Utilization (Self-Reported)

Time Frame: 6-month

Revised Risk Behavior Assessment (RRBA): Self-reported past 30-day use, missed doses, and patterns of use

Secondary Outcomes

  • Drug Use (Biological)(6-month)
  • Drug Use (Self-Reported)(6-month)
  • Perceived social support(6-month)
  • Violence(6-month)

Study Sites (1)

Loading locations...

Similar Trials